The key factors contributing to the risk, diagnosis and treatment of non-tuberculous mycobacterial opportunistic infections

Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States

Mariola Paściak

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/ahem-2021-0050 | Journal eISSN: 1732-2693

Journal RSS Feed

Language: English

Page range: 696 - 710

Submitted on: Feb 4, 2021

Accepted on: May 17, 2021

Published on: Oct 30, 2021

Published by: Hirszfeld Institute of Immunology and Experimental Therapy

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

non-tuberculous mycobacteria,

opportunistic pathogens,

epidemiology,

risk factors,

molecular diagnostics,

Related subjects:

Microbiology and virology,

Medicine,

Basic medical science,

Immunology

© 2021 Anna Grzegorzewicz, Mariola Paściak, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 75 (2021): Issue 1 (January 2021)